FDA & Government News
September 26, 2024
FDA Approves Osimertinib in Stage III NSCLC After Chemoradiotherapy
The ASCO Post
July 18, 2023
First Oral Medication to Treat Moderate-to-Severe Crohn’s Disease Earns FDA Approval
Mount Sinai New York
February 21, 2024
FDA Approves Biweekly Teclistamab Dosing Regimen for Patients With Multiple Myeloma
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
August 05, 2024
FDA Grants Accelerated Approval to T-Cell Therapy for Unresectable or Metastatic Synovial Sarcoma
The ASCO Post
Advertisement
Recommendations
Advertisement